{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:13:16Z","timestamp":1761819196596,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010353","name":"Hellenic Atherosclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cpcardiol.2025.103192","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:59:53Z","timestamp":1760115593000},"page":"103192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An apparent paradox in visit-to-visit blood pressure variability and adverse outcomes in malignant hypertension patients: The West Birmingham malignant hypertension registry"],"prefix":"10.1016","volume":"50","author":[{"given":"Antonios A.","family":"Argyris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alena","family":"Shantsila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Gareth","family":"Beevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Shantsila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory \u03a5.\u0397.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2025.103192_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023397","article-title":"Malignant hypertension: current perspectives and challenges","volume":"11","author":"Boulestreau","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s40292-018-0263-2","article-title":"Definitions and epidemiological aspects of hypertensive urgencies and emergencies","volume":"25","author":"Paini","year":"2018","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0003","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","article-title":"ESC Council on hypertension position document on the management of hypertensive emergencies","volume":"5","author":"van den Born","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0004","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.cpcardiol.2025.103192_bib0005","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia Chairperson","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0006","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"van den Born","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0007","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajh\/hpx008","article-title":"Malignant hypertension revisited-does this still exist?","volume":"30","author":"Shantsila","year":"2017","journal-title":"Am J Hypertens"},{"issue":"2","key":"10.1016\/j.cpcardiol.2025.103192_bib0008","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/HJH.0000000000001913","article-title":"Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort","volume":"37","author":"Rubin","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0009","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00004872-199508000-00013","article-title":"Complications and survival of 315 patients with malignant-phase hypertension","volume":"13","author":"Lip","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ajh.2009.153","article-title":"Improving survival of malignant hypertension patients over 40 years","volume":"22","author":"Lane","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0011","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Long-term renal survival in malignant hypertension","volume":"25","author":"Gonzalez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0012","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jch.12243","article-title":"Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study","volume":"16","author":"Amraoui","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0013","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/HJH.0000000000001446","article-title":"Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham malignant hypertension registry","volume":"35","author":"Shantsila","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0014","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/HJH.0000000000003363","article-title":"Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper *","volume":"41","author":"Parati","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/HJH.0000000000001159","article-title":"Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis","volume":"35","author":"Wang","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0016","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/ageing\/afz178","article-title":"Association between different methods of assessing blood pressure variability and incident cardiovascular disease, cardiovascular mortality and all-cause mortality: a systematic review","volume":"49","author":"Smith","year":"2020","journal-title":"Age Ageing"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0017","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0018","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/ajh\/hpt092","article-title":"Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study","volume":"26","author":"Suchy-Dicey","year":"2013","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/HJH.0000000000000028","article-title":"Second Australian national blood pressure study management C. systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients","volume":"32","author":"Chowdhury","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/M14-2803","article-title":"Visit-to-Visit variability of blood pressure and coronary heart disease, stroke, heart failure, and mortality: a cohort study","volume":"163","author":"Muntner","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0021","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00004872-199411000-00013","article-title":"The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England","volume":"12","author":"Lip","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0022","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0b013e32834cf213","article-title":"Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care","volume":"29","author":"Muntner","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0023","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000229551","article-title":"Reproducibility of measures of visit-to-visit variability in blood pressure after transient ischaemic attack or minor stroke","volume":"28","author":"Howard","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0024","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(10)60309-1","article-title":"Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0025","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/HJH.0b013e32835339ac","article-title":"Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment","volume":"30","author":"Mancia","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0026","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cpcardiol.2025.103192_bib0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/HJH.0b013e3283526e47","article-title":"Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study","volume":"30","author":"Shantsila","year":"2012","journal-title":"J Hypertens"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625002117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625002117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:08:54Z","timestamp":1761818934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625002117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0146280625002117"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103192","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An apparent paradox in visit-to-visit blood pressure variability and adverse outcomes in malignant hypertension patients: The West Birmingham malignant hypertension registry","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103192"}}